Each year, leading lawyers, bankers, PR professionals and other advisors focused on M&A and shareholder activism convene in New Orleans for the annual conference of the Tulane Corporate Law Institute to discuss the latest developments and trends in the area of transactions and corporate securities law. As regular attendees, ICR teams have seen the conversation […]

NEW YORK – March 23rd, 2023 – ICR, a leading strategic communications and advisory firm, is pleased to announce that Eddie Sullivan, PhD, co-founder, President and CEO of SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, high-avidity, fully-human polyclonal antibodies without the need for human donors, […]

The legal cannabis industry has grown rapidly in recent years, with the majority of states now permitting at least some form of cannabis usage. But as with any new industry, there are still many challenges and obstacles that lie ahead. One of the biggest concerns currently facing cannabis companies is the dramatic change in credit […]

“Banking is a confidence game.” So said Andrew Ross Sorkin in his initial post-mortem on covering the stunning 48-hour period during which Silicon Valley Bank (SVB) went from being one of the most influential lenders to the technology and healthcare start-ups over the past 40 years, to collapse, closure and receivership under control of FDIC. […]

In the March 2023 edition of The ICR D.C. Insider, we share our insights and analysis about developments in Washington that could have an immediate and long-term impact on your business. What’s Coming Next In Washington The first month of 2023 has already produced a number of important issues and policy developments, many of which […]